Drug Development in Alzheimer’s Disease: The Contribution of PET and SPECT

Clinical trials aiming to develop disease-altering drugs for Alzheimer’s disease (AD), a neurodegenerative disorder with devastating consequences, are failing at an alarming rate. Poorly defined inclusion-and outcome criteria, due to a limited amount of objective biomarkers, is one of the major conc...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Front Pharmacol
Main Authors: Declercq, Lieven D., Vandenberghe, Rik, Van Laere, Koen, Verbruggen, Alfons, Bormans, Guy
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2016
Fag:
Pharmacology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4814730/
https://ncbi.nlm.nih.gov/pubmed/27065872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00088
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker